Intas Pharmaceuticals Ltd – Generic Meds Mart

Enzamide 40 mg (1 pack / 28 capsules) Enzalutamide

gmm_wpuser — Fri, 14 Nov 2025 11:59:53 +0000

Buy Enzamide 40 mg (28 Capsules) Enzalutamide Online

Enzamide Enzalutamide – 40 mg (1 pack / 28 capsules)

At a Glance

Brand name: Enzamide

Generic name: Enzalutamide

Active ingredient: Enzalutamide

Strength & pack size: Enzamide 40 mg (1 pack / 28 capsules)

Dosage form: Oral hard capsules

Main indication: Advanced and metastatic castration-resistant prostate cancer and other androgen-driven settings as indicated

Therapeutic class: Androgen receptor inhibitor

Use in therapy: Systemic oral treatment alongside ongoing androgen deprivation therapy (ADT)

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Enzamide 40 mg capsules are a generic enzalutamide medicine used in the treatment of advanced and metastatic
prostate cancer. Enzalutamide is a potent oral androgen receptor inhibitor that blocks androgen-driven signalling
inside prostate cancer cells. Enzamide 40 mg (1 pack / 28 capsules) provides a convenient supply of
enzalutamide 40 mg capsules that aligns with your specialist’s written treatment plan.

In many treatment protocols, enzalutamide is used for metastatic castration-resistant prostate cancer (mCRPC) and in other settings such as
metastatic castration-sensitive or non-metastatic castration-resistant disease, according to current guidelines.
Because Enzamide is a generic enzalutamide product, it contains the same active ingredient as branded enzalutamide while offering more accessible pricing in USD
for long-term hormonal therapy.

A typical adult daily dose is 160 mg, often given as four Enzamide 40 mg capsules once daily, although your oncology or urology team may adjust this.
The pack of Enzamide 40 mg (1 pack / 28 capsules) may correspond to a seven-day supply at 160 mg per day or a longer course at reduced doses.
Treatment with Enzamide enzalutamide is usually combined with continuous androgen deprivation therapy (ADT) using LHRH analogues or after surgical castration.

When you buy Enzamide 40 mg online from Generic Meds Mart, you receive generic enzalutamide capsules supplied by licensed manufacturers and authorised distributors
that comply with recognised GMP standards. Discreet outer packaging protects your privacy, while original blisters and cartons preserve all product details such as strength, batch number and expiry date.

This Enzamide 40 mg enzalutamide product is intended only for patients under specialist oncology or urology care.
Generic Meds Mart does not diagnose cancer or alter treatment plans; the information here supports informed discussions with your treating team about access to
generic enzalutamide capsules.

Key Uses

Enzamide 40 mg enzalutamide capsules are generally used for the following indications under specialist supervision:

Treatment of metastatic castration-resistant prostate cancer (mCRPC) alongside ongoing androgen deprivation therapy
Treatment of metastatic castration-sensitive or non-metastatic castration-resistant prostate cancer in selected patients according to recognised guidelines
Continuation or switch therapy in men previously treated with other hormonal agents or chemotherapy when an androgen receptor inhibitor is recommended

Your specialist will determine whether Enzamide 40 mg is appropriate, how it fits into your overall treatment plan and how long
enzalutamide therapy should continue.

How Enzalutamide Works in Chemotherapy

Enzalutamide is an oral hormonal anticancer agent often grouped within modern systemic chemotherapy and targeted hormonal regimens.
Enzamide 40 mg contains enzalutamide, an androgen receptor inhibitor that blocks androgen-driven signalling in
prostate cancer cells.

In androgen-dependent prostate cancer, hormones such as testosterone and dihydrotestosterone bind to androgen receptors, which then move into the cell nucleus and activate genes that promote tumour growth and survival.
Enzamide enzalutamide capsules act at several stages of this process: they bind to the androgen receptor with high affinity, prevent androgen binding, reduce nuclear translocation and limit DNA binding and gene activation.
By disrupting androgen receptor signalling, Enzamide 40 mg can slow tumour growth, lower PSA levels and delay complications of advanced prostate cancer.

Although more targeted than many traditional cytotoxic agents, enzalutamide still has systemic effects and can influence the nervous system, blood pressure and other organs.
Careful monitoring by an experienced oncologist or urologist is therefore essential during Enzamide enzalutamide therapy.

Dosage & Administration

Enzamide 40 mg enzalutamide capsules must always be taken exactly as prescribed by your specialist.
Daily dosing, treatment duration and any dose changes depend on your diagnosis, other medicines and how you tolerate therapy.

Take Enzamide capsules by mouth once daily, with or without food, at approximately the same time each day.
Swallow Enzamide 40 mg capsules whole with water; do not open, crush or chew them unless your doctor or pharmacist gives specific instructions.
Continue concurrent androgen deprivation therapy (ADT) unless your doctor has already performed surgical castration and advised otherwise.
Do not change your dose, skip doses or stop taking Enzamide without clear guidance from your oncology or urology team.
If you miss a dose, follow your doctor’s instructions; do not take extra capsules to compensate unless specifically advised.

Your specialist will schedule regular visits, PSA tests, blood pressure checks and other investigations to monitor your response to
Enzamide enzalutamide and to adjust treatment as needed.

Precautions

Before starting Enzamide 40 mg, inform your doctor about your full medical history and all medicines, supplements and herbal products you use. Important considerations include:

History of seizures, brain injury, stroke or conditions that increase seizure risk
Cardiovascular disease, high blood pressure, heart failure or rhythm disturbances
Pre-existing liver impairment or significant hepatic disease
Previous falls, fractures or conditions affecting bone strength or balance
Use of strong CYP2C8 or CYP3A4 inhibitors or inducers and medicines with a narrow therapeutic index
Use of over-the-counter products or herbal remedies that may interact with enzalutamide

Enzalutamide is not intended for use in women and may harm an unborn baby. Men taking Enzamide 40 mg are usually advised to use effective contraception if their partner may become pregnant, both during treatment and for a period afterwards, as directed by their doctor.

Enzalutamide Side Effects

Common side effects

Many patients experience side effects when starting Enzamide enzalutamide capsules, especially during the first months of therapy. Common reactions may include:

Fatigue, low energy or general tiredness
Hot flushes
Increased blood pressure or worsening of existing hypertension
Headache, dizziness or difficulty concentrating
Back pain, joint pain or muscle discomfort
Mild swelling of the hands, ankles or feet
Mild diarrhea, nausea or reduced appetite

These side effects are often manageable with supportive care or adjustments in overall management, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of enzalutamide are less common but serious and require urgent medical attention. Serious reactions may include:

Seizures, sudden loss of consciousness or unusual movements
Severe confusion, strong headache or visual changes
Very high blood pressure, chest pain or shortness of breath suggesting a cardiovascular event
Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
Repeated falls, new fractures or sudden severe bone pain

If you experience any of these serious symptoms while taking Enzamide 40 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

Store Enzamide 40 mg capsules at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
Keep the capsules in their original blisters and carton until use to protect them from moisture and light.
Keep enzalutamide capsules out of the sight and reach of children and pets.
Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Enzamide enzalutamide capsules.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Enzamide 40 mg enzalutamide capsules at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Enzamide 40 mg online from Generic Meds Mart, you benefit from:

Competitive pricing on generic enzalutamide capsules compared with many local pharmacies
Discreet, plain packaging designed to protect your privacy during shipping
Tracked international delivery options to many destinations
Clear, structured product information to support discussions with your oncologist or urologist
Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed hormonal therapy with transparent conditions and professional handling of each order.

Order Now

Enzamide 40 mg enzalutamide capsules are prescription-only anticancer medicines and must be used strictly under the supervision of an experienced oncologist or urologist.
Before you order Enzamide 40 mg online, ensure that you have a valid prescription or written treatment plan specifying enzalutamide, the daily dose and the intended duration of therapy.

Select Enzamide 40 mg (1 pack / 28 capsules), choose the appropriate quantity, add Enzamide to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your healthcare team.

FAQ about Enzamide 40 mg (Enzalutamide)

Q1: Do I need a prescription to order Enzamide 40 mg?

Yes. Enzamide 40 mg enzalutamide capsules are prescription-only anticancer medicines. You must have a valid prescription or written treatment plan from your oncologist or urologist before ordering.

Q2: Is Enzamide 40 mg the same as branded enzalutamide?

Enzamide 40 mg is a generic enzalutamide product containing the same active ingredient and strength as branded enzalutamide 40 mg capsules. It is used for similar prostate cancer indications but is supplied under a different brand name, often at a more affordable price.

Q3: How many Enzamide 40 mg capsules will I usually take each day?

Many treatment protocols use a total daily dose of 160 mg enzalutamide, which corresponds to four Enzamide 40 mg capsules once daily. However, your exact dose and schedule may differ and must always be defined by your treating specialist.

Q4: Will I continue other hormone treatments while taking Enzamide?

In most cases, Enzamide 40 mg is given in addition to ongoing androgen deprivation therapy, such as LHRH injections or prior surgical castration. You should not stop any hormonal treatments unless your oncology or urology team clearly instructs you to do so.

Q5: What should I do if I feel very dizzy, unusually confused or experience a seizure on Enzamide?

If you notice pronounced dizziness, sudden confusion, a seizure, loss of consciousness or other unusual neurological symptoms while taking Enzamide 40 mg, seek urgent medical care and contact your treating specialist immediately. Do not change or stop treatment on your own; all adjustments must be supervised by your healthcare team.

Q6: Is Enzamide 40 mg the same as Xtandi (Generic Xtandi)?
Enzamide 40 mg is Generic Xtandi — it contains the same active ingredient (enzalutamide) as Xtandi. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), capsule appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.

Cabaxan 60 mg/1.5 mL Cabazitaxel Injection (1 vial)

gmm_wpuser — Sun, 09 Nov 2025 01:50:01 +0000

Buy Cabaxan 60 mg Cabazitaxel Injection Online

Cabaxan 60 mg/1.5 mL Cabazitaxel Injection (1 vial)

At a Glance

Generic Name: Cabazitaxel

Brand Name: Cabaxan

Strength & Pack Size: 60 mg per 1.5 mL vial; 1 vial

Dosage Form & Route: Concentrate for solution for IV infusion after dilution

Therapeutic Class: Taxane antineoplastic (microtubule inhibitor chemotherapy)

Primary Indication: Advanced or metastatic prostate cancer in specialist-directed regimens where cabazitaxel is appropriate

Usual Adult Dose: Dose, schedule, premedication and number of cycles are protocol-specific and must be defined by an oncology specialist

Prescription Status: Prescription-only medicine

Storage: Store in the original carton as directed on the label; protect from light and keep out of reach of children

Product Description

Cabaxan 60 mg/1.5 mL contains cabazitaxel, a taxane chemotherapy medicine supplied as a single vial intended for intravenous (IV) infusion after preparation by trained healthcare professionals. Cabazitaxel is used in specialist oncology settings for advanced or metastatic prostate cancer when a taxane-based approach is selected by the treating team and when the patient’s overall plan, previous treatments, and monitoring requirements support its use. This is not a self-administered medicine and should only be used within a confirmed diagnosis and an oncology-led treatment protocol.

In prostate cancer care, treatment choices are individualized and depend on disease stage, prior therapies, response to earlier lines of treatment, and the patient’s risks for infection, bleeding, or organ toxicity. Cabazitaxel is typically considered when oncologists need an additional systemic chemotherapy option and when the expected benefits and risks have been reviewed in detail. Because chemotherapy can cause significant side effects and requires structured monitoring, Cabaxan should never be started, delayed, or modified without direct guidance from an oncology team. Decisions should also not be made based only on cabazitaxel price or availability; your clinic should confirm the correct strength, vial count, and timing within the treatment plan.

Generic Meds Mart supplies Cabaxan cabazitaxel injection in original packaging sourced through licensed channels. The carton and vial typically show the brand name, strength, active ingredient, batch number, and expiry date so clinics and pharmacies can verify product identity on receipt. Orders are shipped in discreet outer packaging to support privacy, and delivery options may be available internationally where regulations allow. Our role is limited to access and logistics, while all clinical decisions remain with your treating specialists.

Key Uses

Cabaxan cabazitaxel injection is used in advanced or metastatic prostate cancer treatment plans where cabazitaxel-based chemotherapy is clinically appropriate. These regimens are planned and delivered by oncology teams who define the intent of treatment, how response is assessed, and what supportive medicines are needed to reduce risks during therapy. Cabazitaxel may be used when disease has progressed despite prior therapies, but the exact place in therapy depends on local guidance, previous medicines received, and specialist judgment.

Cabazitaxel is administered in controlled infusion settings where patients can be monitored for immediate reactions and where blood tests can be checked regularly. If you need to order cabazitaxel online, coordinate the purchase with your clinic so the correct vial strength and quantity match the planned cycle schedule and supportive care plan.

How Cabazitaxel Works in Chemotherapy

Cabazitaxel is a taxane that works by interfering with microtubules, which are essential structures involved in cell division. By stabilizing microtubules and preventing their normal function during mitosis, cabazitaxel disrupts the ability of rapidly dividing cells to complete cell division. This disruption can lead to cell death, which is one reason taxane chemotherapy is used against cancers that depend on ongoing cell proliferation.

Because this mechanism affects dividing cells, cabazitaxel can also impact normal rapidly dividing tissues, especially in the bone marrow. This explains why myelosuppression, including neutropenia, can be a major risk and why oncology teams rely on planned monitoring and supportive strategies. The balance of benefit and risk depends on the overall regimen, patient factors, and treatment goals defined by your specialist.

Dosage & Administration

Cabaxan is administered by IV infusion after appropriate dilution and preparation by trained healthcare staff. The exact dose, infusion time, cycle length, and number of cycles are defined by the oncology protocol and individualized by your treating team. Premedication may be used to reduce the risk of hypersensitivity reactions, and supportive medicines may be prescribed to lower complication risks during treatment.

Never attempt to self-administer cabazitaxel or to change the schedule without instructions from your oncologist. Blood counts and clinical status are usually reviewed before each cycle, and treatment may be delayed or adjusted if side effects or laboratory changes occur. Always provide your clinic with a complete list of medicines and supplements, because interactions and overlapping toxicities can influence safety. If an infusion is missed or delayed, only the treating team should decide how to reschedule therapy.

Precautions

Cabazitaxel can cause significant reductions in white blood cells, increasing the risk of serious infections. Fever, chills, sore throat, new cough, burning when urinating, or any signs of infection should be reported urgently, especially during chemotherapy cycles. Bleeding risk can rise if platelet counts fall, so unusual bruising, bleeding gums, black stools, or blood in urine should also be assessed promptly.

Hypersensitivity reactions can occur with taxane infusions, which is why infusion centers monitor patients closely and may use premedication. Severe diarrhea, dehydration, persistent vomiting, or severe weakness can become dangerous if not treated early. Liver function can affect chemotherapy safety, so patients with hepatic impairment require careful specialist assessment. Pregnancy should be avoided during treatment, and contraception planning should be discussed with your oncology team.

Cabazitaxel Side Effects

Common side effects

Common cabazitaxel side effects may include fatigue, nausea, vomiting, reduced appetite, taste changes, hair loss, mild numbness or tingling, diarrhea or constipation, and generalized weakness. Blood tests may show changes in blood counts, including anemia, neutropenia, or thrombocytopenia, which can require observation, supportive care, or dose adjustments. Many common effects can be managed within a specialist-led plan, but worsening symptoms should be reported promptly rather than managed by changing treatment independently.

fatigue and weakness
nausea or vomiting
diarrhea or constipation
reduced appetite and taste changes
hair loss
mild numbness or tingling
low blood counts on laboratory tests

Serious side effects

Serious side effects require urgent medical attention and may include severe neutropenia with infection or sepsis, high fever, severe or persistent diarrhea with dehydration, major bleeding, severe allergic or infusion reactions, and severe shortness of breath or chest symptoms. If you experience high fever, confusion, fainting, uncontrolled diarrhea, severe abdominal pain, heavy bleeding, or rapidly worsening symptoms, seek urgent care and tell clinicians you are receiving cabazitaxel.

fever or signs of severe infection
severe diarrhea, dehydration, or inability to keep fluids down
major bleeding or black stools
severe allergic or infusion reaction symptoms
severe shortness of breath or chest pain
confusion, fainting, or rapidly worsening weakness

Storage

Store Cabaxan in the original carton under the storage conditions listed on the product label and protect it from light. Chemotherapy vials are typically stored and handled by a clinic or pharmacy under controlled procedures, including safe preparation and disposal. Do not use the vial after the expiry date on the carton or vial label, and follow local guidance for handling cytotoxic medicines.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for specialty oncology medicines such as Cabaxan cabazitaxel injection. We supply products in original packaging from licensed channels with batch and expiry details to support verification by oncology clinics and pharmacies. Prices are displayed in USD, checkout is secure, and shipments are packed in discreet outer cartons.

Where regulations allow, international delivery options and tracking can help coordinate procurement with planned infusion appointments and monitoring schedules. Generic Meds Mart does not replace your oncologist or infusion center. All decisions about whether cabazitaxel is appropriate, how it is dosed, and how side effects are managed must be made by qualified healthcare professionals.

Order Now

Before you buy Cabaxan 60 mg/1.5 mL online from Generic Meds Mart, you should have a confirmed diagnosis of advanced prostate cancer and a treatment plan agreed with your oncology team that includes cabazitaxel. Your clinic should confirm the exact vial strength, the number of vials required per cycle, and the monitoring schedule for blood counts and side effects. Once the plan is confirmed, select Cabaxan (1 vial), add it to your cart, and complete secure checkout in USD.

Do not start or change chemotherapy on your own. If you develop fever, severe diarrhea, signs of serious infection, heavy bleeding, chest symptoms, or rapidly worsening weakness, seek urgent medical care and inform clinicians that you are receiving cabazitaxel.

FAQ about Cabaxan (Cabazitaxel)

Q1: What is Cabaxan used for?

Cabaxan contains cabazitaxel, a taxane chemotherapy used in specialist-directed regimens for advanced or metastatic prostate cancer when your oncology team determines it is appropriate.

Q2: Is Cabaxan taken as tablets or given by infusion?

Cabaxan is an injection intended for IV infusion after dilution and must be prepared and administered by trained healthcare professionals in an infusion setting.

Q3: How often is cabazitaxel given?

Cabazitaxel is given in cycles, but the exact schedule and number of cycles depend on your oncology protocol, prior treatments, and how you tolerate therapy, so only your treating team can define it.

Q4: What monitoring is needed during treatment?

Monitoring typically includes regular blood counts and clinical checks for infection, bleeding risk, hydration status, and other side effects, with frequency defined by your oncology team.

Q5: What symptoms should prompt urgent contact with a doctor?

Seek urgent help for fever, chills, signs of infection, severe diarrhea or dehydration, heavy bleeding, severe shortness of breath, chest pain, confusion, or rapidly worsening weakness during cabazitaxel treatment.

Azadine 100 mg 1 vial (Azacitidine) Injection

gmm_wpuser — Sat, 08 Nov 2025 21:06:36 +0000

Buy Azadine 100 mg Azacitidine Injection Online

Azadine 100 mg Azacitidine Injection (1 vial)

At a Glance

Generic Name: Azacitidine

Brand Name: Azadine 100 mg

Strength & Pack Size: 100 mg azacitidine, 1 vial of lyophilised powder for injection

Dosage Form & Route: Powder for suspension or solution, for subcutaneous (SC) or intravenous (IV) administration after reconstitution

Therapeutic Class: Hypomethylating antineoplastic agent

Primary Indications: Myelodysplastic syndromes (MDS) and selected acute myeloid leukemia (AML) cases, as per local label

Typical Patient Setting: Adults treated in specialist haematology–oncology centres with access to intensive monitoring

Mode of Action: Inhibits DNA methyltransferase, leading to hypomethylation and direct cytotoxic effects on abnormal marrow cells

Key Benefits: Proven improvement in blood counts and survival in higher-risk MDS and certain AML populations when used appropriately

Precautions: Requires close monitoring of blood counts, organ function and injection site reactions; hospital infrastructure recommended

Storage: Store in the original carton at the temperature stated in the leaflet; protect from light and follow reconstitution stability guidance

Product Description

Azadine 100 mg azacitidine injection is a hypomethylating agent used in the treatment of myelodysplastic syndromes (MDS) and in selected acute myeloid leukemia (AML) settings according to local prescribing information and specialist guidelines. Azacitidine targets abnormal bone marrow cells by interfering with DNA methylation and exerting direct cytotoxic effects, helping to restore more normal blood cell production over time.

Each vial of Azadine 100 mg contains 100 mg of azacitidine as a sterile lyophilised powder that must be reconstituted with an appropriate diluent before administration. Depending on local protocols, the reconstituted suspension or solution is given either subcutaneously or intravenously in repeated treatment cycles. Because of the risks of myelosuppression, infection and other serious side effects, Azadine 100 mg injection is used under the supervision of experienced haematologists and oncologists in facilities that can provide supportive care and regular monitoring.

When you buy Azadine 100 mg online from Generic Meds Mart, you receive original manufacturer vials in sealed cartons with clearly visible batch numbers and expiry dates. Products are sourced only from licensed distributors experienced in oncology and haematology supply chains. Outer shipping boxes are neutral, without visible references to MDS, AML or chemotherapy, to protect patient privacy, while maintaining complete traceability for pharmacies and clinics. Our mission is to support access and logistics; all treatment decisions remain with your specialist team.

Key Uses

Azadine 100 mg azacitidine injection is used in adults for myelodysplastic syndromes (MDS) and certain acute myeloid leukemia (AML) presentations, as defined in regional labels and guidelines. Typical indications include:

Myelodysplastic syndromes (MDS), including subtypes with excess blasts, where disease-modifying hypomethylating therapy is indicated.
Selected cases of AML, particularly those evolving from MDS or with lower blast percentages, where azacitidine-based regimens are supported by local protocols.

The choice to use Azadine 100 mg is individualized and considers patient age, performance status, cytogenetic and molecular risk, comorbidities and eligibility for alternative options such as intensive chemotherapy or stem cell transplantation. Azacitidine injection is often chosen for higher-risk MDS or for patients in whom traditional intensive regimens would be inappropriate or poorly tolerated.

How Azacitidine Works in Chemotherapy

Azacitidine, the active ingredient in Azadine 100 mg, is a cytidine analogue that exerts its antineoplastic effects through dual mechanisms. At lower concentrations, azacitidine incorporates into RNA and DNA and inhibits DNA methyltransferase, leading to hypomethylation of DNA. This hypomethylation can reactivate silenced tumour suppressor genes and modify abnormal gene expression patterns in dysplastic bone marrow cells.

At higher concentrations, azacitidine has direct cytotoxic effects on rapidly dividing cells, leading to cell death. In the context of myelodysplastic syndromes and certain AML subtypes, these mechanisms help reduce the burden of abnormal progenitor cells and support recovery of more normal haematopoiesis over repeated treatment cycles. Response to azacitidine therapy builds gradually, so clinicians often continue treatment for multiple cycles before judging benefit, provided tolerance and safety profiles remain acceptable.

Dosage & Administration

The dosing of Azadine 100 mg azacitidine injection is defined by body surface area and local prescribing information. A commonly used regimen in MDS involves administration of azacitidine for a set number of days in a 28-day cycle, given either subcutaneously or intravenously. Regimens, exact dose in mg/m², route and number of treatment cycles may vary based on label, institutional practice and individual patient factors.

Azadine vials must be reconstituted with the recommended diluent, using aseptic technique, and the resulting suspension or solution is administered within defined stability periods. Administration is performed only by trained healthcare professionals. Blood counts, kidney and liver function, as well as clinical status, are closely monitored before and during each cycle. Dose delays, reductions or interruptions may be necessary in response to myelosuppression, infections or other toxicities. Patients should never attempt to reconstitute or administer azacitidine themselves.

Precautions

Before starting Azadine 100 mg, your haematology team will review your full medical history, including prior treatments, performance status, infection risk, kidney and liver function and concurrent medications. Baseline blood counts and biochemistry help guide eligibility and dosing. Because azacitidine can cause profound myelosuppression, the risk of infections and bleeding must be considered, and prophylactic or early-intervention strategies may be used where appropriate.

Patients may be counselled about the potential need for blood or platelet transfusions, antimicrobial prophylaxis, hospital admission during infections and frequent laboratory monitoring. Azacitidine injection is not suitable for all patients; those with severe organ dysfunction or uncontrolled infections may require stabilisation before treatment or alternative approaches. Women and men of childbearing potential are usually advised to use effective contraception during treatment and for a period afterwards, as azacitidine can harm a developing baby. Breastfeeding is generally not recommended during therapy.

Azacitidine Side Effects

Common side effects

Common azacitidine side effects during Azadine 100 mg therapy include nausea, vomiting, diarrhoea or constipation, loss of appetite, fatigue, weakness, injection site reactions (for subcutaneous administration), mild rash, headache and low-grade fever. Haematologic side effects are very frequent and may involve reduced white cells, red cells and platelets, leading to higher risk of infections, anaemia and bruising or bleeding.

Many of these reactions can be managed with supportive medicines such as antiemetics, analgesics, topical measures for injection sites, growth factors in selected cases, transfusions and dose adjustments or cycle delays. Patients are encouraged to report any new or worsening symptoms promptly so that the medical team can intervene early and adjust treatment if needed.

Serious side effects

Serious azacitidine adverse effects require urgent medical attention and may include severe neutropenia with life-threatening infections, sepsis, severe thrombocytopenia with major bleeding, serious allergic reactions, pronounced liver or kidney injury, severe gastrointestinal events and rare but significant cardiac complications.

Warning signs to watch for include high or persistent fever, chills, severe sore throat, shortness of breath, chest pain, confusion, uncontrolled bleeding or bruising, black stools, vomiting blood, severe abdominal pain, markedly reduced urine output, yellowing of the skin or eyes or sudden swelling. If any of these occur during treatment with Azadine 100 mg azacitidine injection, emergency medical help should be sought immediately and healthcare professionals informed that you are receiving a hypomethylating agent.

Storage

Azadine 100 mg vials should be stored in their original cartons at the temperature specified in the product leaflet, protected from light and kept out of reach of children. They should not be frozen. After reconstitution, the azacitidine suspension or solution has a limited stability window and specific storage conditions, which must be followed closely by the pharmacy and infusion or day-care unit. Unused reconstituted product and materials used for preparation and administration must be disposed of as cytotoxic waste according to local regulations.

Why Buy from Generic Meds Mart

Generic Meds Mart is focused on improving access to essential haematology–oncology therapies such as Azadine 100 mg azacitidine injection, particularly in regions where availability and pricing can be barriers. We collaborate only with licensed manufacturers and authorised distributors who follow recognised quality and safety standards and provide full batch traceability. By supplying Azadine 100 mg in sealed original packaging, we support hospital pharmacies and clinics in verifying product authenticity and integrity.

Orders are processed in USD using secure online payment systems. Shipments are prepared in neutral outer packaging without visible oncology references, with the option for tracked delivery where available. This helps centres plan treatment cycles and ensure that azacitidine vials arrive in time for scheduled therapy. Our role is purely logistical; decisions about whether azacitidine is suitable, how many cycles to give and how to manage side effects are entirely the responsibility of the treating haematology–oncology team.

Order Now

Before arranging to buy Azadine 100 mg azacitidine injection online from Generic Meds Mart, you should have a confirmed diagnosis of myelodysplastic syndrome or AML where azacitidine is recommended, and a clear treatment plan from your specialist detailing dose, route, schedule and monitoring requirements. Your team will explain how azacitidine therapy fits into your overall care, expected benefits, potential risks and the importance of regular follow-up.

Once this plan is in place, your clinic or you, in agreement with your doctors, can determine how many Azadine 100 mg vials are needed per cycle and for the planned number of cycles. After you select the required quantity, you can complete secure checkout in USD. You should never start, stop or modify azacitidine treatment on your own; any changes must be guided by your haematology–oncology team. Generic Meds Mart exists to provide a discreet, reliable supply channel for Azadine 100 mg azacitidine injection, while all complex clinical decisions remain with your specialists.

FAQ about Azadine (Azacitidine)

Q1: What conditions is Azadine 100 mg used to treat?

Azadine 100 mg contains azacitidine, a hypomethylating agent used for myelodysplastic syndromes (MDS) and selected acute myeloid leukemia (AML) cases in adults, according to local prescribing information and specialist guidelines.

Q2: Is Azadine 100 mg an infusion or an injection under the skin?

Azadine 100 mg azacitidine can be given as a subcutaneous injection or as an intravenous infusion, depending on local protocols and patient factors. The powder in the vial is reconstituted by healthcare professionals, who then administer it using the route and schedule defined in your treatment plan.

Q3: How many treatment cycles of azacitidine will I need?

The number of azacitidine cycles varies between patients. Many people require multiple cycles, often at least six, before a full assessment of response is made, provided side effects remain manageable. Your haematology team will explain how many cycles they recommend and how they will evaluate benefit over time.

Q4: Will I need to stay in hospital for Azadine treatment?

Some patients receive Azadine 100 mg as day-care treatment, while others may need hospital admission, especially early in therapy or if complications arise. Decisions about inpatient versus outpatient management depend on your overall health, blood counts, infection risk and local practice.

Q5: Can Azadine 100 mg cure my disease?

In some patients, azacitidine can lead to durable remissions and significantly improved survival, but not everyone achieves a complete cure with hypomethylating therapy alone. For some individuals, Azadine 100 mg may serve as a bridge to other treatments such as stem cell transplantation. Your haematologist is best placed to discuss realistic goals of therapy in your specific situation.

Q6: Is Azadine 100 mg the same as Vidaza (Generic Vidaza)?
Azadine 100 mg is Generic Vidaza — it contains the same active ingredient (azacitidine) as Vidaza. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), vial appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.

Arsenox 10 mg Injection – Arsenic Trioxide for APL

gmm_wpuser — Sat, 08 Nov 2025 21:02:07 +0000

Buy Arsenox 10 mg Arsenic Trioxide Injection Online

Arsenox 10 mg Arsenic Trioxide Injection

At a Glance

Generic Name: Arsenic Trioxide

Brand Name: Arsenox 10 mg

Strength & Pack Size: 10 mg arsenic trioxide injection, single-use vial (hospital pack)

Dosage Form & Route: Sterile concentrate for solution for IV infusion, after dilution in a hospital or infusion centre

Therapeutic Class: Antineoplastic agent for acute promyelocytic leukemia (APL)

Primary Indications: APL with t(15;17) / PML-RAR-α positivity, newly diagnosed or relapsed, as per local label

Typical Patient Setting: Managed by specialist haematology–oncology teams in hospital or dedicated infusion units

Mode of Action: Induces differentiation and apoptosis of malignant promyelocytes through arsenic-mediated pathways

Key Benefits: Effective option in APL protocols, often combined with all-trans retinoic acid (ATRA) under strict monitoring

Precautions: Requires intensive monitoring of ECG, electrolytes, blood counts and signs of differentiation syndrome

Storage: Store below the temperature stated in the product leaflet, in the original carton, protected from light; do not freeze

Product Description

Arsenox 10 mg contains arsenic trioxide, an intravenous anticancer medicine used in selected patients with acute promyelocytic leukemia (APL) characterized by the PML-RAR-α fusion. Arsenic trioxide injection has become an important component of modern APL therapy, particularly in regimens aimed at inducing remission or treating relapse when standard approaches alone are insufficient. Because of the risk of serious, sometimes life-threatening adverse events, Arsenox 10 mg injection is used exclusively in hospital settings under the direct supervision of experienced haematologists and oncologists.

Each Arsenox 10 mg vial provides a sterile arsenic trioxide concentrate that must be diluted in an appropriate infusion solution before administration. Dosing schedules, combination partners such as all-trans retinoic acid (ATRA) and supportive measures are defined by specialist protocols and local prescribing information. The goal of treatment is to achieve and maintain remission while closely managing complications such as differentiation syndrome, QT interval prolongation, electrolyte disturbances and myelosuppression.

Generic Meds Mart supplies Arsenox 10 mg arsenic trioxide injection in original manufacturer packaging sourced from licensed oncology distributors. Vials are shipped in strict accordance with storage recommendations, and outer parcels are kept neutral so there is no visible reference to leukemia or chemotherapy on the outside. Batch numbers, expiry dates and storage instructions remain fully visible on the vial and carton, allowing hospital pharmacies and clinics to verify the product on receipt. Our role is limited to access and logistics; all treatment decisions and clinical monitoring remain with your specialist team.

Key Uses

Arsenox 10 mg arsenic trioxide injection is used in carefully selected cases of acute promyelocytic leukemia (APL) with confirmed PML-RAR-α positivity, according to local product information and expert guidelines. Typical uses include:

Induction therapy in newly diagnosed APL alongside or in defined sequences with all-trans retinoic acid (ATRA) in patients considered suitable for arsenic trioxide–based regimens.
Treatment of relapsed or refractory APL following earlier therapies, again within specialist protocols that specify dosing, combination partners and monitoring requirements.

The exact place of arsenic trioxide injection within the treatment pathway depends on local practice, risk stratification, patient characteristics and evolving data. Arsenox 10 mg is not used for general acute myeloid leukemia (AML) or other malignancies unless explicitly covered by the label and specialist guidelines.

How Arsenic Trioxide Works in Chemotherapy

Arsenic trioxide, the active ingredient in Arsenox 10 mg, exerts complex effects on malignant promyelocytes in APL. At clinically used concentrations, arsenic trioxide promotes differentiation and apoptosis (programmed cell death) of leukemic promyelocytes that carry the PML-RAR-α fusion protein. This fusion disrupts normal retinoic acid signalling and contributes to the differentiation block characteristic of APL.

By acting on the fusion protein and associated pathways, arsenic trioxide helps restore more normal maturation and induces death of abnormal cells, leading to reductions in leukemic burden. Mechanisms include degradation of PML-RAR-α, effects on mitochondrial function, generation of reactive oxygen species and modulation of signalling cascades that control cell survival. When used alongside ATRA in appropriate patients, arsenic trioxide–based regimens have transformed APL from a highly fatal disease into a highly curable subtype of acute leukemia in many settings.

Dosage & Administration

Arsenox 10 mg arsenic trioxide injection must only be prescribed and administered by physicians experienced in the management of acute leukemia and in facilities capable of intensive monitoring and emergency supportive care. The concentrate is never given as a rapid IV push or undiluted. Instead, the contents of the vial are diluted in a compatible infusion solution and administered as an intravenous infusion over a period specified in the prescribing information and local protocol.

Dosing regimens differ between induction, consolidation and relapse treatment schedules and may be weight-based or flat-dose, depending on local guidance. During therapy, patients typically undergo frequent blood counts, ECGs and electrolyte checks, and may require inpatient admission, especially early in treatment or when complications arise. For safety reasons, you must never attempt to self-administer Arsenox 10 mg or handle vials at home; all preparation and administration are carried out by trained healthcare professionals.

Precautions

Before starting arsenic trioxide therapy with Arsenox 10 mg, the specialist team will review your full medical history, baseline ECG, electrolytes (particularly potassium and magnesium), kidney and liver function and concurrent medications. Particular care is taken with medicines that prolong the QT interval or that affect electrolyte levels, as arsenic trioxide can further increase these risks.

Patients are closely monitored for signs of differentiation syndrome (also known as APL differentiation syndrome), including unexplained weight gain, difficulty breathing, pleural or pericardial effusions, hypotension and renal impairment. Prompt recognition and treatment with corticosteroids and supportive care can be life-saving. Prophylactic or empiric measures may be used according to protocol. Women and men of childbearing potential are usually advised to use effective contraception during treatment, and arsenic trioxide is generally avoided during pregnancy unless the potential benefits clearly outweigh the risks in a life-threatening situation.

Arsenic Trioxide Side Effects

Common side effects

Common arsenic trioxide side effects observed during Arsenox 10 mg therapy can include fatigue, nausea, vomiting, diarrhoea, abdominal discomfort, headache, mild rash, pruritus, transient liver enzyme elevations and peripheral oedema. Blood tests may show decreases in white cells, red cells or platelets as part of disease and treatment effects. Changes in ECG parameters, including QT prolongation, and electrolyte disturbances may also be observed and must be managed proactively.

Many of these effects can be controlled with supportive medications, careful fluid and electrolyte management, temporary adjustments in infusion schedules and close multidisciplinary monitoring. Regular communication between the patient, nursing team and physicians is essential so that new symptoms are recognised early.

Serious side effects

Serious arsenic trioxide adverse effects require urgent medical attention and may necessitate treatment interruption, dose adjustment or discontinuation. These include severe differentiation syndrome, marked QT prolongation with risk of arrhythmias such as torsades de pointes, sudden cardiac events, severe electrolyte abnormalities, significant hepatotoxicity, serious infections, tumour lysis syndrome and multi-organ dysfunction in critically ill patients.

Warning signs demanding immediate hospital review include chest pain, palpitations, fainting, severe shortness of breath, rapid weight gain, new or worsening swelling, confusion, seizures, high fever, reduced urine output, severe jaundice, uncontrolled bleeding or any rapid deterioration in overall condition. If any of these occur, emergency medical care should be sought without delay, and healthcare providers must be told that the patient is receiving arsenic trioxide–based therapy.

Storage

Arsenox 10 mg arsenic trioxide vials should be stored at the temperature specified in the product leaflet (typically controlled room temperature or refrigerator conditions), in the original carton, protected from light and never frozen. Vials must be kept out of the reach of children and non-clinical staff. Once prepared for infusion, the diluted solution has defined in-use stability parameters that must be followed strictly by the pharmacy and infusion unit. Disposal of unused solution, vials and infusion materials must comply with local cytotoxic and hazardous waste regulations.

Why Buy from Generic Meds Mart

Generic Meds Mart is focused on supporting access to critical haematology–oncology medicines such as Arsenox 10 mg arsenic trioxide injection, especially where local supply or pricing can be challenging. We work exclusively with licensed manufacturers and authorised distributors that adhere to recognised quality standards and maintain traceable batch records. By supplying Arsenox 10 mg in sealed original packaging, we help hospital pharmacies, clinics and infusion centres verify that they have received the correct medicine and strength for their APL protocols.

Orders are processed in USD via secure online checkout. Shipments are prepared in neutral outer packaging without any visible reference to leukemia, arsenic trioxide or chemotherapy, helping protect patient privacy. Where available, tracked shipping options allow centres to align deliveries with planned induction or consolidation cycles, minimising the risk of treatment delays. Our role remains logistical and administrative; all clinical decisions on whether, when and how to use arsenic trioxide injection are the responsibility of your specialist team.

Order Now

Before arranging to buy Arsenox 10 mg online through Generic Meds Mart, your haematology–oncology team should have established a confirmed diagnosis of APL with PML-RAR-α positivity and defined an arsenic trioxide–based treatment plan that includes dosing, monitoring and supportive care. Arsenox 10 mg injection must only be used within such structured protocols and in appropriate hospital facilities.

Once the plan is in place, the treating centre can determine how many Arsenox 10 mg vials are required for induction and consolidation and coordinate procurement accordingly.
Patients and families should not attempt to manage ordering independently without agreement from the clinical team. Generic Meds Mart provides a discreet, verifiable supply channel for Arsenox 10 mg arsenic trioxide injection, while all complex medical decisions about APL therapy remain firmly with your treating specialists.

FAQ about Arsenox (Arsenic Trioxide)

Q1: What is Arsenox 10 mg used for?

Arsenox 10 mg contains arsenic trioxide, used primarily in acute promyelocytic leukemia (APL) with confirmed PML-RAR-α positivity, either in newly diagnosed patients within modern induction and consolidation regimens or in relapsed/refractory APL, according to local guidelines and product information.

Q2: Is Arsenox 10 mg an infusion or a tablet?

Arsenox 10 mg is not a tablet. It is a sterile arsenic trioxide concentrate for solution for infusion, which must be diluted and given as an intravenous infusion in a hospital or specialist infusion centre. It is never taken by mouth or self-administered at home.

Q3: How long will treatment with arsenic trioxide last?

The duration of arsenic trioxide therapy depends on whether it is being used for induction, consolidation or relapse treatment, as well as on response, tolerance and protocol design. Treatment courses are defined by haematology–oncology specialists and may involve several weeks or months of scheduled infusions. Only your treating team can specify the exact duration for your case.

Q4: What monitoring is needed during Arsenox treatment?

Patients receiving Arsenox 10 mg typically require frequent blood counts, liver and kidney function tests, electrolyte measurements and ECGs to monitor QT interval and rhythm. Additional imaging or assessments may be needed if there are concerns about differentiation syndrome, fluid accumulation or organ dysfunction.

Q5: Can Arsenox 10 mg be combined with other APL treatments?

Yes. In many modern APL protocols, arsenic trioxide injection is combined or sequenced with all-trans retinoic acid (ATRA) and other supportive measures. The exact combination and timing depend on risk stratification, local practice and evolving evidence. Decisions about combinations are made solely by the haematology–oncology team in charge of your care.

Q6: Is Arsenox 10 mg the same as Trisenox (Generic Trisenox)?
Arsenox 10 mg is Generic Trisenox — it contains the same active ingredient (arsenic trioxide) as Trisenox. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), vial/ampoule appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.